Former President, Research & Development · NOVAVAX INC (NVAX)

Filip Dubovsky

A named executive officer of NOVAVAX in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,554,368

Salary $336,254Stock awards $776,160Bonus $250,000

FY2023: $1,934,392

5th of 6 named executive officers at Novavax by FY2024 total.

6 named officers on file for NOVAVAX, FY2024

Filip Dubovsky’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • NVAX’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NOVAVAX’s whole pay program stands against its peers

  • NOVAVAX’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NVAX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2025 (DEF 14A).

Free

Get Filip Dubovsky’s full pay file as a PDF — free

More than this page: up to 10 years of Filip’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Filip Dubovsky compensation by year

NOVAVAX Summary Compensation Table · all 2 fiscal years held
In US dollars, as NOVAVAX reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$659,200$336,254
Bonus$0$250,000
Stock awards$406,560$776,160
Option awards$669,064$0
Non-equity incentive$186,368$0
Pension and deferred compensation$0$0
All other$13,200$191,954
Total$1,934,392$1,554,368

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NOVAVAX INC DEF 14A filed April 29, 2025, accession 0001000694-25-000013, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NOVAVAX INC filed document, accession 0001000694-25-000013. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2025.

$1.9M
$1.6M
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU144,000$1,157,760—
RSU38,886$312,643—
RSU5,376$43,223—
Option37,902—$6.97
Option31,251—$6.09
Option7,561—$77.77

Per the Outstanding Equity Awards at Fiscal Year-End table in NOVAVAX INC's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

NOVAVAX’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
John JacobsPresident and CEO$5,087,461
James KellyEVP, Chief Financial Officer and Treasurer$1,829,489
Elaine O'HaraEVP, Chief Strategy Officer$1,638,116
John TrizzinoPresident and Chief Operating Officer$1,633,417
Filip Dubovsky · this pageFormer President, Research & Development$1,554,368
Mark CaseyEVP, Chief Legal Officer and Corporate Secretary$1,062,334

The full NOVAVAX compensation record

free company brief

This page is one person within NOVAVAX's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NOVAVAX's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Filip Dubovsky's compensation dossier · One-time report. No refunds.